✦ LIBER ✦

The oral antihyperglycaemic agent nateglinide [`Starlix'] has been approved in Switzerland for the treatment of type 2 diabetes mellitus.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral agents for the treatment of type 2

✍ Richard A. Harrigan; Michelle S. Nathan; Philip Beattie 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Cost-effectiveness of oral hypoglycaemic

✍ Ward, Alexandra; O’Brien, Judith A; Salas, Maribel 📂 Article 📅 2005 🏛 Informa plc 🌐 English ⚖ 138 KB

Insulin lispro in the treatment of patie

✍ Edward J. Bastyr III; Martin E. Johnson; Michael E. Trautmann; James H. Anderson 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 865 KB

Pharmacoeconomic Evaluation of the Oral

✍ Ryazhenov, V.V.; Emchenko, I.V. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Relationship between treatments with ins

✍ Ippei Kanazawa; Toru Yamaguchi; Masahiro Yamamoto; Toshitsugu Sugimoto 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 178 KB

Current practice of insulin and oral hyp

✍ Mykola Khalangot 📂 Article 📅 2007 🏛 Elsevier 🌐 English ⚖ 50 KB